Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice

Journal of Neural Transmission

Volumn 103, Issue 3, 1996, Pages 307-314

  Tutka, P ^a   Turski, W A ^a   Kleinrok, Z ^a   Czuczwar, S J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Aminophylline; D CPP ene; GYKI 52466; Seizures; Strychnine; Valproate

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; AMINOPHYLLINE; ANTICONVULSIVE AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; STRYCHNINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONVULSION; ELECTROCONVULSIVE THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINOPHYLLINE; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BENZODIAZEPINES; CONVULSANTS; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; N-METHYLASPARTATE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SEIZURES; STRYCHNINE; VALPROIC ACID;

EID: 0029670505     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271242     Document Type: Article

References (19)

1. Aebischer B, Frey P, Haerter HP, Herrling PL, Mueller W, Olverman HJ, Watkins JC (1989) Synthesis and NMDA antagonistic properties of the enantiomers of 4-3-phosphonopropyl-piperazine-2-carboxylic acid (CPP) and of the unsaturated analogue (E-4-(3-phosphonoprop-2-enyl)-piperazine-2-carboxylic acid (CPP-ene). Helv Chim Acta 72: 1043-1051
2. Borowicz KK, Kozicka M, Kleinrok Z, Czuczwar SJ (1993) Influence of aminophylline and 8-(p-sulfophenyl)theophylline on the anticonvulsive action of diphenyl-hydantoin, phenobarbital, and valproate against maximal electroshock-induced convulsions in mice. J Neural Transm [Gen Sect] 93: 157-163
3. Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ (1995) The non-competitive AMPA/ kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol 281: 319-326
4. Chu N-S (1981) Caffeine- and aminophylline-induced seizures. Epilepsia 22: 85-94
5. Czuczwar SJ, Turski WA, Ikonomidou C, Turski L (1985) Aminophylline and CGS 8216 reverse the protective action of diazepam against electroconvulsions in mice. Epilepsia 26: 693-696
6. Czuczwar SJ, Ikonomidou C, Kleinrok Z, Turski L, Turski WA (1986) Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 27: 204-208
7. Czuczwar SJ, Jäckel R, Löscher W (1987a) Effects of aminophylline and enprofylline on the protective activity of phenobarbital against amygdala-kindled seizures in rats. Epilepsy Res 1: 234-238
8. Czuczwar SJ, Kleinrok Z, Turski L, Turski WA (1987b) Effect of aminophylline and enprofylline upon the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 28: 383-386
9. Czuczwar SJ, Janusz W, Szczepanik B, Wamil A, Kleinrok Z (1989) Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci Res 6: 470-474
10. Czuczwar SJ, Włodarczyk D, Gasior M, Kleinrok Z (1991) Is there a glycinergic component in the mechanisms of action of common antiepileptic drugs? In: Klee MR, Lux HD, Speckmann EJ (eds) Physiology, pharmacology and development of epileptogenic phenomena. Springer, Berlin Heidelberg New York Tokyo, pp 255-257
11. 2+ channel agonist, BAY k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists. Eur J Pharmacol 264: 103-106
12. Donevan SD, Rogawski MA (1993) GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA-/kainate receptor responses. Neuron 10: 51-59
13. Jensen MH, Jorgensen S, Nielsen H, Sanchez R, Andersen PK (1985) Is theophylline induced seizure in man caused by inhibition of cerebral 5'-nucleotidase activity? Acta Pharmacol Toxicol 55: 331-334
14. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99-113
15. Löscher W, Hönack D (1991) Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther 256: 432-440
16. Meldrum B (1992) Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res 12: 189-197
17. Neering IR, McBurney RN (1984) Role for microsomal Ca storage in mammalian neurons? Nature 309: 158-160
18. Rogawski MA (1992) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14: 325-331
19. Smith SE, Durmuller N, Meldrum B (1991) The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol 201: 179-183